Celularity CELU
NASDAQ CELU
$1.43 -0.01 (-0.35%)
At close: Sep 10, 2026 · 4:00 PM EDT

Celularity (CELU) Assets Average (2019 - 2025)

Celularity's (CELU) quarterly Assets Average came in at $57.3 million in Q4 2025, down 56.19% year-over-year from $130.8 million in Q4 2024, and down 51.15% quarter-over-quarter from $117.3 million in Q3 2025.

Analysis

Celularity (CELU) Assets Average (2019 - 2025) Analysis & Trends

Celularity (CELU) has reported Assets Average for 7 consecutive years, with $57.3 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Assets Average fell 56.19% year-over-year to $57.3 million in Q4 2025; TTM through Dec 2025 was $57.3 million, a 56.19% decrease from a year earlier, with the FY2025 full-year figure at $66.5 million, down 51.9% from the prior year.
  • Assets Average was $57.3 million for Q4 2025 at Celularity, down from $117.3 million in the prior quarter.
  • Over five years, Assets Average peaked at $433.2 million in Q3 2022 and troughed at $57.3 million in Q4 2025.
  • A 5-year average of $250.7 million and a median of $206.0 million in 2021 frame the typical range for Assets Average.
  • Across the five-year window, Assets Average surged 105.44% in 2022 and slumped 64.08% in 2023, its largest moves.
  • Over 5 years, Assets Average stood at $431.2 million in 2021, then slipped by 2.81% to $419.1 million in 2022, then tumbled by 64.08% to $150.5 million in 2023, then decreased by 13.14% to $130.8 million in 2024, then slumped by 56.19% to $57.3 million in 2025.
  • The last three Assets Average figures came in at $57.3 million (Q4 2025), $117.3 million (Q3 2025), and $124.6 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 1.45 Bn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 2.69 Bn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 920.60 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 1.67 Bn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 881.90 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 1.43 Bn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 154.46 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 3.18 Bn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 494.25 Mn
10 Celularity 36.35 Mn 30.17 Mn -3.27 Mn 57.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 57.29 Mn
Sep 30, 2025 117.26 Mn
Jun 30, 2025 124.58 Mn
Mar 31, 2025 130.78 Mn
Dec 31, 2024 130.76 Mn
Sep 30, 2024 132.17 Mn
Jun 30, 2024 139.66 Mn
Mar 31, 2024 143.85 Mn
Dec 31, 2023 150.54 Mn
Sep 30, 2023 201.81 Mn
Jun 30, 2023 304.42 Mn
Mar 31, 2023 381.74 Mn
Dec 31, 2022 419.09 Mn
Sep 30, 2022 433.23 Mn
Jun 30, 2022 431.77 Mn
Mar 31, 2022 424.17 Mn
Dec 31, 2021 431.21 Mn
Sep 30, 2021 288.35 Mn
Jun 30, 2021 210.17 Mn
Mar 31, 2021 361.47 Mn